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OBJECTIVE—Ethnic minorities with diabetes typically have lower rates of cardiovascular
outcomes and higher rates of end-stage renal disease (ESRD) compared with whites. Diabetes
outcomes among Asian and Pacific Islander subgroups have not been disaggregated.
RESEARCH DESIGN AND METHODS—We performed a prospective cohort study
(1996–2006) of patients enrolled in the Kaiser Permanente Northern California Diabetes Regis-
try. There were 64,211 diabetic patients, including whites (n = 40,286), blacks (n = 8,668),
Latinos (n = 7,763), Filipinos (n = 3,572), Chinese (n = 1,823), Japanese (n = 951), Pacific
Islanders (n = 593), and South Asians (n = 555), enrolled in the registry. We calculated incidence
rates (means 6 SD; 7.2 6 3.3 years follow-up) and created Cox proportional hazards models
adjusted for age, educational attainment, English proficiency, neighborhood deprivation, BMI,
smoking, alcohol use, exercise, medication adherence, type and duration of diabetes, HbA1c,
hypertension, estimated glomerular filtration rate, albuminuria, and LDL cholesterol. Incidence
of myocardial infarction (MI), congestive heart failure, stroke, ESRD, and lower-extremity am-
putation (LEA) were age and sex adjusted.
RESULTS—Pacific Islander women had the highest incidence of MI, whereas other ethnicities
had significantly lower rates of MI than whites. Most nonwhite groups had higher rates of ESRD
thanwhites. Asians had ~60% lower incidence of LEA compared with whites, African Americans,
or Pacific Islanders. Incidence rates in Chinese, Japanese, and Filipinos were similar for most
complications. For the three macrovascular complications, Pacific Islanders and South Asians
had rates similar to whites.
CONCLUSIONS—Incidence of complications varied dramatically among the Asian sub-
groups and highlights the value of a more nuanced ethnic stratification for public health sur-
veillance and etiologic research.
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Individuals of Asian origin comprise~4.7% of the U.S. population (1), andpeople from the Pacific Islands com-
prise another 0.3% of the population
(2). It has been estimated that by the
year 2050, 10% of the U.S. population
will be of Asian or Pacific Islander ances-
try (3). Yet, there is little systematic data
collection on Asian Americans and Pacific
Islanders and almost no long-term out-
come studies among these ethnic groups
by country of origin.
Both Asians (4,5) and Pacific Island-
ers (6) have been recognized as having
higher rates of type 2 diabetes than whites
and other ethnic minority groups in the
U.S. (3). Explanations for this higher di-
abetes prevalence have included cultural,
socioeconomic, behavioral, and genetic
factors (4,5). However, among those
with diabetes, it is unclear whether Asians
and Pacific Islanders have similar inci-
dence of complications relative to whites
or other ethnic groups. Inprevious diabetes
research, data for Asians and Pacific
Islanders was aggregated, and this hetero-
geneous group had a significantly lower
incidence of cardiovascular disease out-
comes and lower-extremity amputations
(LEAs) and higher end-stage renal disease
(ESRD) rates over 2 years of follow-up
compared with whites (7). However, the
insufficient numbers of individuals in
each ethnic category and short follow-up
time precluded examination of specific
subgroups.
We disaggregated data from East
Asians, South Asians, Filipinos, and Pa-
cific Islanders from a large, diverse cohort
of diabetic patients enrolled in the Kaiser
Permanente managed care organization in
northern California and determined the
incidence of major diabetes complica-
tions after ~7 6 3 years of follow-up or
413,500 person-years. We compared the
risk of each complication in four separate
Asian groups and Pacific Islanders with
that in whites, African Americans, and La-
tinos after adjusting for several potential
explanatory factors. We hypothesized
that the incidence of complications will
differ significantly between each specific
Asian and Pacific Islander subgroup com-
pared with whites, and aggregation of all
Asians together obscures this variation.
RESEARCH DESIGN AND
METHODS—The study sampling frame
was derived from a well-characterized
population with diabetes in the Kaiser
Permanente Northern California Diabe-
tes Registry (n = ~225,000) (7). Kaiser
Permanente Northern California is a fully
c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c
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integrated health care delivery system
that provides comprehensive medical
care to .3 million members (30% of the
catchment area). Except for the extremes
of income, the demographic characteris-
tics of the patient population are similar
to those of the overall population of the
region.
During 1994–1997, all noninstitu-
tionalized Diabetes Registry members
aged .19 years were mailed a question-
naire or contacted for a computer-assisted
telephone interview in English, Spanish,
Mandarin, or Cantonese (n = 95,953). Af-
ter excluding those who denied having
diabetes and those who had left the health
plan, there were 81,286 eligible individ-
uals for survey administration. Of these,
69,722 (86%) completed the survey. We
excluded another 5,511 people with un-
known race/ethnicity, mixed racial/ethnic
background, or those belonging to racial/
ethnic groups with insufficient size for
analysis (e.g., Vietnamese, Koreans, and
Indonesians), leaving a total study popu-
lation of 64,211 individuals. In our anal-
yses, we present each racial/ethnic group
separately and also aggregate the four
Asian groups (Chinese, Filipino, Japa-
nese, and South Asian) together to ad-
dress our hypothesis.
Measures
Race/ethnicity of the respondents was
based on self-report. Socioeconomic
status was captured by self-reported edu-
cational attainment. Neighborhood dep-
rivation index was calculated using the
1990 U.S. Census with a validated meth-
odology. Limited English proficiency, cat-
egorized as always or often having
problems speaking and/or understanding
English, was categorized using adminis-
trative records. Behavioral variables in-
cluded current smoking status and alcohol
use and whether the subject reported
using exercise to treat their diabetes at
the time of the survey. BMI was calculated
based on self-reported height and weight
at the time of the survey. We calculated
multi-interval, continuous-medication
gaps, a well-validated metric of medication
adherence (percentage of time without
sufficient medications) based on phar-
macy utilization for oral glucose-lowering
medication.
We determined type and duration of
diabetes and family history of diabetes.
We assessed a history of hypertension
using a self-reported measure and phar-
macy records for antihypertensive drug
use. HbA1c levels, LDL cholesterol, HDL
cholesterol, triglycerides, microalbumin-
uria, and estimated glomerular filtration
rate (eGFR) were ascertained from Kaiser’s
regional laboratory within 1 year of base-
line individual survey date.
Outcome measures
We evaluated the incidence of five di-
abetes complications: myocardial infarc-
tion (MI), congestive heart failure (CHF),
stroke (ischemic or hemorrhagic), ESRD,
and nontraumatic LEA over 7 6 3 years
of follow-up. The ICD-9-CM codes listed
as either the primary hospitalization dis-
charge diagnosis or the ICD-10-CM
code for underlying cause of death on
the death certificate were used to identify
MI, CHF, and stroke (Supplementary
Data). ESRD was identified from Kaiser
Permanente’s ESRD treatment registry or
defined by chronic renal failure listed as
the underlying cause of death on the
death certificate. The LEA procedures
were identified from discharge codes
and/or current procedural terminology
codes. Emergency events serviced by
non–Kaiser Permanente hospitals were
captured via a claims reimbursement da-
tabase for outside medical services. Mor-
tality and cause of death were ascertained
with a validated program, the California
Automated Mortality Linkage System.
We have previously reported validation
studies of these end points in this popu-
lation (7).
Statistical analyses
We used a direct adjustment method,
with the whole diabetic cohort as the
standard population to determine age-
and sex-adjusted incidence densities for
each outcome by race. The incidence
densities are presented as the number of
events per 1,000 person-years with 95%
CIs. We calculated age- and sex-adjusted
rates and fully adjusted rate ratios com-
paring each ethnic group to whites using
Poisson regression for those with com-
plete data.
Cox proportional hazards models
were specified to calculate adjusted haz-
ard ratios (HRs) for each ethnic minority
group versus the reference category
(whites). We excluded individuals
with a prevalent history of the same di-
agnosis for each of the outcomes ana-
lyzed, focusing only on incident events.
We pooled the data for men and women
because the interaction between ethnicity
and sex was not significant for all out-
comes except for MI.We specified a series
of Cox regression models in sequence to
assess potentially explanatory variables
after verifying that there were no viola-
tions of the proportionality assumption.
First, we created a base model that was
adjusted for sex and age (demographic
model). Then, we added socioeconomic
factors (education, English-language pro-
ficiency, and neighborhood deprivation
score) for the second model (SES model).
The third model added BMI. A fourth
model (behavior model) added smoking
status, alcohol intake, self-reported use of
exercise as a treatment for diabetes, and
medication adherence for oral diabetes
medications. The fifth and final model
(clinical model) added characteristics
specific to diabetes to the behavior model,
including type of diabetes, diabetes dura-
tion, hypertension history, baseline
HbA1c (,7, 7–8, 8–10, and .10%),
LDL cholesterol (,100 vs. $100 mg/
dL), elevated urinary albumin excretion
(microalbuminuria or proteinuria vs. nor-
moalbuminuria), and chronic kidney dis-
ease stages based on standard cut points
for eGFR.
Not all study participants answered
all the relevant survey questions. More-
over, in the beginning of the study (1996),
the clinical assessments (LDL cholesterol,
HbA1c, and others) were not collected as
frequently or routinely as is common to-
day. Because the analyses were restricted
to complete cases, which can introduce
bias if the data are not missing completely
at random, we used a multiple-imputation
method to replace the missing variables
of our study. We used the Markov Chain
Monte Carlo method (8), which assumes
multivariate normality to impute all miss-
ing values tomake 10 complete datasets, as
implemented in SAS Proc MI. After the 10
complete datasets were analyzed using
standard SAS procedures (Proc TPHREG),
the MIANALYZE procedure was used to
generate valid statistical inferences by com-
bining results from the 10 analyses. In ad-
dition, we performed a sensitivity analysis
using observations for which no data were
missing.
RESULTS—Of 64,211 diabetic pa-
tients, ~63% were white, 13% were Afri-
can American, 12% were Latino, 6% were
Filipino, 3% were Chinese, 1% were
Japanese, 1% were Pacific Islanders, and
1% were South Asians. There were a total
of 6,901 (11%) Asian participants in
aggregate and an additional 593 (1%)
Pacific Islanders included in this analysis.
The total follow-up time was ~413,500
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person-years or a mean of 7.26 3.3 years
from 1996 to 2006.
Each of the eight ethnic groups were
~50% women, except for the Chinese
(42% women) and South Asian (30%
women) groups (Table 1). Mean age dif-
fered somewhat by ethnicity, with Japa-
nese respondents being oldest (aged 626
11 years) and South Asians being the
youngest (aged 53 6 11 years). College
graduation rates were highest among
South Asians (55%), Filipino (47%), Chi-
nese (37%), and Japanese (33%) and low-
est among Pacific Islanders (14%) and
Latinos (12%). There were high propor-
tions of African Americans (47%) and La-
tinos (31%) living in the most deprived
neighborhoods. Chinese Americans (33%)
were most likely to have limited English
proficiency. The average BMI was similar
for whites, African Americans, Latinos,
and Pacific Islanders (~30 6 6 kg/m2 for
each) and lower for the other four Asian
subgroups (mean 25–26 kg/m2 per
group). The prevalence of smoking was
highest among African Americans (16%)
and Pacific Islanders (14%) and lowest
among the Chinese and South Asian
(#5%) groups. The mean duration of di-
agnosed diabetes was similar for whites,
African Americans, Latinos, and Japanese
(10 6 10 years for each group) but lower
for Chinese (96 11 years), Filipinos (86
8 years), Pacific Islanders (8 6 9 years),
and South Asians (86 7 years). More than
half of all participants in each ethnic group
were using oral hypoglycemic medica-
tions for diabetes treatment, had a family
history of diabetes, and had hypertension.
We calculated the crude and age- and
sex-adjusted incidence rates per ethnic
group for each of the five diabetes com-
plications (Table 2). We also show the
aggregated rates of the four Asian sub-
groups together for comparison with the
individual Asian subgroups. The fully ad-
justed rate ratios comparing each ethnic
group to whites are displayed. The table
shows the HR (95% CI) for each ethnic
group compared with whites for each of
the diabetes complications.
There were a total of 6,088 people
with incident MI during the follow-up
period. The aggregated Asian incidence
rate (10.8 [95% CI 9.9–11.8]) completely
obscured the wide range of rates across
the four Asian subgroups. The highest
incidence of MI occurred in Pacific Island-
ers (18.5 [14.3–23.5] per 1,000 person-
years), and the lowest incidence was in
Chinese (9.2 [7.7–11.0] per 1,000 person-
years). After age and sex adjustment, the
rates were attenuated, but Pacific Islanders
had the highest incidence of MI (10.1 per
1,000 person-years) of all groups, whereas
Japanese (3.3 per 1,000 person-years) had
the lowest incidence of MI, with whites in
the middle of this range (5.9 per 1,000
person-years). These differences between
subgroups persisted despite multivariate
adjustment for several potentially explan-
atory factors (Fig. 1). In fully adjusted
models, compared with whites, most ra-
cial/ethnic groups had significantly lower
hazards of MI. However, Pacific Islanders
had significantly higher risk (HR 1.29
[1.01–1.66]), and South Asians were not
significantly different from whites. Fur-
thermore, sex did not modify the associa-
tion between ethnicity and MI risk, except
for Pacific Islanders where women had a
markedly higher risk (1.94 [1.40–2.68])
than men (0.87 [0.59–1.27]; P for interac-
tion = 0.001).
The total number of first-time diag-
noses for CHF was 5,062 during follow-
up. The highest age- and sex-adjusted
incidence was among African Americans
(5.2 per 1,000 person-years), and the
lowest incidence was among Chinese
(2.5 per 1,000 person-years). The range
of CHF incidence rates among the four
Asian groups was narrower for CHF than
for MI (from 2.4 to 3.3). In fully adjusted
models, there was no significant differ-
ence between African Americans, Filipinos,
Pacific Islanders, and South Asians com-
pared with whites. The risk of CHF was
significantly lower for Latinos, Japanese,
and Chinese compared with whites.
There were 4,825 strokes during fol-
low-up. Similar to CHF, the age- and sex-
adjusted incidence was highest among
African Americans, and the lowest rates
occurred among Japanese (2.8 per 1,000
person-years). The fully adjusted com-
parison with whites showed a similar
pattern as CHF, with Latinos, Japanese,
Chinese, and Filipinos having signifi-
cantly lower risk than whites and the
other ethnic groups having similar risk to
whites.
There were 2,340 new cases of ESRD.
The adjusted incidence of ESRD was not
uniformly higher for all ethnic minority
groups compared with whites; the inci-
dence was lower among South Asians (1.1
per 1,000 person-years) and Chinese (1.9
per 1,000 person-years) compared with
whites (2.4 per 1,000 person-years) and
higher among all of the other groups.
Aggregating all four Asian groups to-
gether (2.9 per person-year [95% CI
2.0–4.0]) obscured the wide range of
ESRD outcomes among each of the sub-
groups. However, after adjusting for all
potentially explanatory groups of vari-
ables, the hazards of ESRD were signifi-
cantly higher for each ethnic group
compared with whites, except for South
Asians for whom the ESRD risk was sim-
ilar to whites.
There were a total of 2,291 first-time
cases of LEA. The highest age- and sex-
adjusted incidence was among African
Americans and Pacific Islanders (2.6 per
1,000 person-years for each), and the
lowest rates were among Chinese and
Filipinos (0.7 per 1,000 person-years for
each). Compared with whites, all four
Asian subgroups had significantly lower
risk of LEAs, whereas risk for Pacific
Islanders, African Americans, and Latinos
was not significantly different than that in
whites.
Restricting our Cox models to those
with complete data on all covariates, we
found some change in risk estimates
among the ethnic groups with smaller
numbers of patients (Pacific Islanders and
South Asians), mainly for the macrovas-
cular disease outcomes. For MI, the risk
among Pacific Islanders compared with
whites was attenuated (HR 1.03 [95% CI
0.38–2.81]), and the risk became some-
what stronger among South Asians (2.00
[0.97–4.12]). For CHF, the risk was
strengthened among South Asians (2.26
[0.91–5.60]). Estimates for stroke, ESRD,
and LEAs did not change substantively.
CONCLUSIONS—In a large, inte-
grated, managed care organization, where
participants have uniform access to health
care, we found that Asians and Pacific
Islanders have substantial variation in the
incidence of diabetes complications that
differs significantly from whites or other
ethnic minority groups. The difference in
diabetes complications among the ethnic
groups was not fully explained by de-
mographic, socioeconomic, behavioral,
and disease-related clinical measures. Al-
though most ethnic minority groups with
diabetes have significantly lower risk of
MI compared with whites, women from
the Pacific Islands have almost twice the
risk of MI compared with white women.
The four Asian subgroups had ~60–70%
lower risk of LEAs compared with whites
or other ethnic groups. For most compli-
cations, the incidence rates observed in
Chinese and Japanese were similar to
each other. For the three cardiovascular
disease outcomes, Pacific Islanders and
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Table 1—Baseline characteristics of 64,211 participants with diabetes by race/ethnic group*
Characteristics White
African
American Latino Filipino Chinese Japanese
South
Asian
Pacific
Islander
n 40,286 8,668 7,763 3,572 1,823 951 555 593
Follow-up time (mean 6 SD) 7.0 6 8.9 7.3 6 3.2 7.5 6 3.2 7.5 6 3.2 7.8 6 3.1 8.0 6 3.3 7.4 6 3.3 7.0 6 3.3
Female sex 45 53 49 51 42 52 30 44
Age (years) (mean 6 SD) 61 6 13 59 6 12 58 6 12 56 6 11 60 6 12 63 6 11 53 6 11 54 6 10
Education achieved
,High school 13 17 36 13 19 9 13 26
High school graduate/GED 30 26 28 15 20 30 14 33
Some college 32 38 24 25 24 29 18 27
College graduate or higher 25 18 12 47 37 33 55 14
Neighborhood deprivation index
Fourth quartile (poorest) 11.6 47.4 31.0 19.5 13.2 12.0 12.8 21.8
Limited English proficiency
No English spoken 0.7 0.1 13.9 8.2 33.5 5.8 9.5 6.8
BMI (kg/m2)
Underweight (,19.0) 1 1 0 1 2 1 1 1
Normal (19.0–24.9) 21 14 16 21 27 19 28 22
Overweight (25.0–29.9) 36 36 39 23 23 21 21 37
Obese ($30.0) 43 48 45 55 48 59 50 40
Current smoker (%) 12 16 11 9 4 9 5 14
Alcohol (drinks/week)
Moderate use (7–19) 7 4 5 2 2 2 7 4
Heavy use ($20) 2 1 2 0 0 1 1 1
Uses exercise as part of treatment 48 50 47 59 47 52 52 57
Diabetes type
Type 1 7 4 3 1 2 1 5 3
Type 2, using insulin 20 26 20 12 13 17 13 19
Type 2, oral hypoglycemic 51 54 56 66 47 58 62 60
Type 2, diet controlled 22 16 21 20 27 23 20 18
First-degree family history of diabetes 51 65 72 59 53 57 69 72
Diabetes duration (years)
0–9 61 61 62 72 65 62 69 69
10–19 24 25 25 20 22 22 34 21
$20 16 14 13 8 12 16 8 10
HbA1c category (%)
,7 28 25 23 18 28 25 20 16
7–8 24 20 19 21 23 26 25 17
8–10 30 28 31 33 31 33 34 32
$10 18 27 27 28 18 16 21 35
Self-monitored blood glucose per guidelines 46 34 38 33 34 42 38 29
History of hypertension 68 72 56 61 63 65 47 62
HDL ,45 mg/dL for women or ,35 mg/dL
for men 63 43 62 56 50 54 58 62
LDL $100 mg/dL 87 89 87 91 86 89 89 91
Triglycerides $200 mg/dL 46 20 46 38 38 47 37 43
Taking a cholesterol-lowering medication 14 10 10 15 14 21 11 15
Microalbuminuria 14 15 14 17 15 18 10 17
eGFR (mL/min)
$90 16 29 29 26 22 22 27 24
60–89 53 49 50 51 54 55 60 50
30–59 28 17 17 19 20 19 11 19
15–29 2 3 2 2 3 3 1 3
,15 1 2 2 2 2 2 1 5
*Values represent % unless otherwise stated.
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Disparate diabetes complication rates in Asians
South Asians had incidence similar to
whites, with the exception that Pacific
Islander women had substantively higher
MI risk. Outcomes in Filipinos were in-
termediate to those in the other Asian
groups.
MI outcomes among diabetic patients
of various ethnic groups have been ex-
amined in previous studies (9), but most
have either not included several different
Asian subgroups or have not disaggre-
gated data for their Asian subgroups. Our
findings are consistent with a previous re-
port from the Kaiser Diabetes Registry
with only 2 years of follow-up that found
that all Asians, blacks, and Latinos had
significantly lower risk of MI compared
with whites after adjustment for several
covariates (7). Other U.S. studies have
shown higher MI rates among African
Americans. Several studies from the U.K.
(10–12) have compared diabetic South
Asians with white Europeans, finding
equal risk of MI complications between
these two ethnic groups, consistent with
our findings. Singaporian studies have
compared heart disease between three
separate Asian groups: Chinese, Malay,
and Asian Indians and found that the
Asian Indians with diabetes had higher
heart disease risk than the Chinese or
Malay (13). Little outcomedata are available
for diabetic Pacific Islanders; studies from
New Zealand have reported significantlyT
ab
le
2—
C
on
ti
nu
ed
O
u
tc
om
es
W
hi
te
A
fr
ic
an
A
m
er
ic
an
La
ti
n
o
A
ll
A
si
an
s
Fi
lip
in
o
C
hi
ne
se
Ja
pa
n
es
e
So
ut
h
A
si
an
Pa
ci
fi
c
Is
la
n
de
r
U
na
dj
us
te
d
ra
te
(9
5%
C
I)
5.
3
(5
.1
–
5.
6)
6.
4
(5
.7
–
7.
0)
5.
2
(4
.6
–
5.
8)
2.
0
(1
.7
–
2.
5)
2.
0
(1
.5
–
2.
6)
2.
1
(1
.4
–
3.
0)
2.
8
(1
.7
–
4.
3)
1.
0
(0
.3
–
2.
5)
5.
9
(3
.8
–
8.
8)
A
ge
-
an
d
se
x-
ad
ju
st
ed
ra
te
(9
5%
C
I)
2.
4
(2
.1
–
2.
6)
2.
6
(2
.2
–
3.
1)
2.
1
(1
.8
–
2.
5)
0.
9
(0
.5
–
1.
2)
0.
7
(0
.5
–
1.
0)
0.
7
(0
.3
–
1.
1)
1.
3
(0
.5
–
2.
4)
1.
0
(2
0.
1
to
3.
5)
2.
6
(1
.5
–
4.
0)
Fu
lly
ad
ju
st
ed
ra
te
ra
tio
(9
5%
C
I)
1.
0
(r
ef
er
en
ce
)
0.
75
(0
.4
0–
1.
40
)
1.
17
(0
.6
5–
2.
10
)
0.
29
(0
.1
2–
0.
69
)
0.
34
(0
.1
0–
1.
14
)
0.
18
(0
.0
2–
1.
31
)
0.
26
(0
.0
4–
1.
90
)
0.
38
(0
.0
5–
3.
11
)
0.
0
*F
u
lly
ad
ju
st
ed
ra
te
ra
ti
o
co
m
p
ar
in
g
th
e
ra
te
in
ea
ch
et
h
ni
c
gr
ou
p
w
ith
th
at
of
w
hi
te
s
us
in
g
a
Po
is
so
n
re
gr
es
si
on
m
od
el
.
Figure 1—HRs and 95% CIs for each ethnic group (vs. whites [reference group]) for each
diabetes complication.
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higher rates of cardiovascular risk factors,
cardiovascular disease, and mortality
compared with Europeans (14). Simi-
larly, native Hawaiian and other Pacific
Islanders have very high rates of cardio-
metabolic disease compared with other
U.S. ethnic groups (3,15,16). To our
knowledge, this is the first report of signif-
icantly higher risk of MI among diabetic
Pacific Islander women compared with all
ethnic groups. Higher rates of traditional
cardiovascular risk factors have been re-
ported among Pacific Islander women
(16), whichmay explain the higherMI risk.
ESRD is a well-recognized microvas-
cular complication of diabetes. Several
studies have found that most ethnic mi-
nority groups have a higher risk of ESRD
comparedwith whites (9), but there is less
known about Asian subgroups. Studies
from Europe have reported that South
Asians have higher risk of diabetic ESRD
than whites in the U.K. (17,18) and in the
Netherlands (19), which was not appar-
ent in our analysis possibly as a result of
the small numbers of South Asians.
LEAs were significantly less common
in the Asian subgroups than all other
ethnic groups. Previous studies (20,21)
have identified a lower risk of diabetic
foot ulcers and amputations among South
Asians compared with Europeans, with
potential explanations including better
preservation of nerve function, peripheral
vascular function, low smoking rates, and
shorter height (22). Higher rates of dia-
betic foot–related complications have
been reported in indigenous people of
western Australia compared with non-
indigenous people (23), but that study
did not adjust for differences in socioeco-
nomic, behavioral, and disease-related
variables.
We were limited in using data col-
lected from a self-administered ques-
tionnaire for many covariates and to
individuals who could speak English,
Spanish, or Chinese languages. Ethnicity
was self-reported in narrower categories
than most studies but still did not include
specific nationality of origin. We did not
have information about nativity, genera-
tional status, length of time since immi-
gration to the U.S., cultural beliefs, or
acculturation to the U.S., which may ex-
plain some of the differences in diabetes
outcomes. We also did not have data on
dietary patterns, stress, secondhand
smoke exposure, and other environmental
determinants of disease outcomes.
Exercise was assessed by a question
asking whether the patient used exercise
to treat their diabetes but did not capture
intensity or frequency and may underes-
timate the effect of physical activity as an
explanatory factor. BMI was calculated by
self-reported weight and height, which
may underestimate the effect of adiposity.
We did not measure waist circumference,
which may be a better indicator of adi-
posity in Asians (24). Diabetes severity
and control were measured at baseline
using available laboratory data and self-
reported measures. Although all partici-
pants in this study population were
enrolled in Kaiser Permanente and there-
fore had access tomedical care, we did not
have data on the number of primary care
visits or other health care utilization
measures, which may explain the differ-
ences in diabetes outcomes. However,
previous studies from this health care set-
ting have shown uniform offering of care
by ethnic group (25). Limitations with us-
ing diagnostic and procedural codes for
classification of our diabetes outcomes
have been discussed previously (7). Mis-
classification of outcomes should not dif-
fer by ethnic group and would tend to
bias our results toward the null.
In a health care system offering uni-
form access to care, we found widely
disparate rates of diabetes complications
among the four Asian groups and Pacific
Islanders. This large, diverse cohort al-
lowed comparison of eight racial/ethnic
groups, which has not been reported
previously. Pacific Islander women were
at highest risk of MI compared with all
other groups. Similar to whites, Pacific
Islanders and South Asians had high rates
of all cardiovascular complications. All
Asian groups had significantly lower LEA
rates than all other groups. Classifying all
Asian ethnic groups as a single group
greatly obscures the sometimes substantial
ethnic differences and may preclude iden-
tification of particularly vulnerable sub-
groups that deserve intensified disease
management. Disaggregating Asian and
Pacific Islander subgroups is imperative
for disease surveillance and may enhance
understanding of disease etiology.
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